This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: ICD

In brief

August 2016 Br J Cardiol 2016;23:98–9

In brief

BJCardio Staff

Abstract

A new portable monitoring device (CardioMessenger Smart, Biotronik) has been launched in the USA. Roughly the size of a smartphone, the device keeps pacemaker, implantable cardioverter defibrillator, and insertable cardiac monitor patients connected to their physician remotely. The device automatically transmits daily reports of cardiac activity via worldwide cellular networks to physicians without intervention from the patient. It also provides fully customisable alerts that can be programmed to the physician’s specifications. Studies have found that home monitoring can significantly reduce hospitalisation, stroke and mortality. The manuf

| Full text
Book review

December 2015 Br J Cardiol 2015;22:133

Book review

Dewi E Thomas

Abstract

Editors: Burri H, Deharo J-C, Israel C Publisher: Oxford University Press, Oxford, 2015 ISBN: 978-0-19-872777-4 Price: £59.99 This case-based study guide for implantable device troubleshooting is composed of 70 ‘real-life’ cases involving pacemakers, implantable cardio-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices. It is aimed at all physicians and physiologists involved in the management of patients with implantable devices, and is the first in a series of specialist ‘handbooks’ produced by the European Heart Rhythm Association (EHRA). As such it particularly geared towards those sitting the EHRA affilia

| Full text
Barriers to cardiac device innovation

December 2015 Br J Cardiol 2015;22:136 doi:10.5837/bjc.2015.040

Barriers to cardiac device innovation

Nick Linker

Abstract

Dr Nick Linker (President, British Heart Rhythm Society) Despite the need to implant more devices in patients and to develop new, innovative, devices there remain major obstacles. The recent report from the Cardiovascular Round Table4 highlights some of these barriers. Delays in implementation of guidelines, and in dissemination of new devices, vary throughout Europe, and are related to a number of factors such as funding, complex R&D lifecycles and regulatory issues. The cumulative result is inconsistent delivery both across Europe and within the UK. In Germany, hospitals can access an innovation fund set up by health insurers to exploit

| Full text
Syncope in a patient with cardiac sarcoidosis

July 2015 Br J Cardiol 2015;22:(3) doi:10.5837/bjc.2015.027 Online First

Syncope in a patient with cardiac sarcoidosis

Khwaja Nizamuddin, Farhan Shahid, Richard P W Cowell

Abstract

Introduction Cardiac sarcoidosis can present in a broad spectrum of entities ranging from a benign condition, which is diagnosed incidentally, to a potentially serious disease leading to sudden cardiac death, which only becomes apparent at autopsy, as is the case in 5% of the affected population.1 Due to its subtle, but also sometimes fatal presentation, cardiac sarcoid is hugely underdiagnosed, and awareness of such cases should be brought to light whenever possible. This case report highlights the importance of being aware of the potential presentations of cardiac involvement in patients with sarcoidosis and the general investigations and m

| Full text

December 2012 Br J Cardiol 2013;20:14–5 Online First

News from the American Heart Association Scientific Sessions 2012

BJCardio Staff

Abstract

FREEDOM: CABG beats PCI in diabetes patients with multi-vessel disease Coronary artery by-pass graft (CABG) surgery was associated with better outcomes than percutaneous coronary intervention (PCI) in patients with diabetes with multi-vessel coronary artery disease in the FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multi-vessel Disease) trial. Senior FREEDOM investigator, Dr Valentin Fuster (Mount Sinai School of Medicine, New York, USA), said the results (table 1) would change practice. He estimated that patients in this study represent about a quarter of patients undergoing PCI. In

| Full text
Incidence screening for primary prevention ICDs based on UK guidelines following STEMI

November 2012 Br J Cardiol 2012;19:170–2 doi:10.5837/bjc.2012.030

Incidence screening for primary prevention ICDs based on UK guidelines following STEMI

Ellen Berry, Helen Padgett, Melanie Doyle, Arif J Ahsan, Andrew D Staniforth

Abstract

Introduction The implantable cardioverter defibrillator (ICD) implant rate within the UK remains significantly lower than that across Europe; furthermore, there is marked inequity in access to ICD implant between regions within the UK.1 The need for an ICD is self-evident in secondary prevention patients successfully resuscitated from ventricular tachycardia (VT) or ventricular fibrillation (VF). Intuitively, therefore, it would seem most likely that underperformance and inequity of access in the UK resides chiefly within the primary prevention patient group. A number of international randomised-controlled trials have identified patient subgr

| Full text

July 2004 Br J Cardiol 2004;11:261-2

Living with an ICD – the price of saving a life

Violet R Henry, Sharon Smart, Salma Akram, Katherine McGrath, Ian Wright, Sophie Blackman, Nicholas S Peters

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now